DOCSLIB.ORG

Mouse Morc3 Conditional Knockout Project (CRISPR/Cas9)

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Mouse Morc3 Conditional Knockout Project (CRISPR/Cas9) https://www.alphaknockout.com Mouse Morc3 Conditional Knockout Project (CRISPR/Cas9) Objective: To create a Morc3 conditional knockout Mouse model (C57BL/6J) by CRISPR/Cas-mediated genome engineering. Strategy summary: The Morc3 gene (NCBI Reference Sequence: NM_001045529 ; Ensembl: ENSMUSG00000039456 ) is located on Mouse chromosome 16. 17 exons are identified, with the ATG start codon in exon 1 and the TAA stop codon in exon 17 (Transcript: ENSMUST00000202261). Exon 3 will be selected as conditional knockout region (cKO region). Deletion of this region should result in the loss of function of the Mouse Morc3 gene. To engineer the targeting vector, homologous arms and cKO region will be generated by PCR using BAC clone RP23-221E11 as template. Cas9, gRNA and targeting vector will be co-injected into fertilized eggs for cKO Mouse production. The pups will be genotyped by PCR followed by sequencing analysis. Note: Mice homozygous for a null allele die at or within a day of birth. Exon 3 starts from about 4.0% of the coding region. The knockout of Exon 3 will result in frameshift of the gene. The size of intron 2 for 5'-loxP site insertion: 2750 bp, and the size of intron 3 for 3'-loxP site insertion: 813 bp. The size of effective cKO region: ~633 bp. The cKO region does not have any other known gene. Page 1 of 8 https://www.alphaknockout.com Overview of the Targeting Strategy Wildtype allele gRNA region 5' gRNA region 3' 1 3 4 17 Targeting vector Targeted allele Constitutive KO allele (After Cre recombination) Legends Exon of mouse Morc3 Homology arm cKO region loxP site Page 2 of 8 https://www.alphaknockout.com Overview of the Dot Plot Window size: 10 bp Forward Reverse Complement Sequence 12 Note: The sequence of homologous arms and cKO region is aligned with itself to determine if there are tandem repeats. No significant tandem repeat is found in the dot plot matrix. So this region is suitable for PCR screening or sequencing analysis. Overview of the GC Content Distribution Window size: 300 bp Sequence 12 Summary: Full Length(7133bp) | A(26.15% 1865) | C(19.37% 1382) | T(33.3% 2375) | G(21.18% 1511) Note: The sequence of homologous arms and cKO region is analyzed to determine the GC content. No significant high GC-content region is found. So this region is suitable for PCR screening or sequencing analysis. Page 3 of 8 https://www.alphaknockout.com BLAT Search Results (up) QUERY SCORE START END QSIZE IDENTITY CHROM STRAND START END SPAN -------------------------------------------------------------------------------------------------------------- browser details YourSeq 3000 1 3000 3000 100.0% chr16 + 93840945 93843944 3000 browser details YourSeq 251 1056 1499 3000 90.9% chr9 + 22407384 22408011 628 browser details YourSeq 240 1144 1533 3000 85.6% chr17 + 27044576 27044917 342 browser details YourSeq 229 1158 1499 3000 94.3% chr4 + 132903361 132903763 403 browser details YourSeq 225 980 1499 3000 93.8% chr9 - 56902613 56903172 560 browser details YourSeq 225 1132 1499 3000 93.5% chr15 - 6618807 6619165 359 browser details YourSeq 222 980 1499 3000 87.8% chr13 + 55390227 55390579 353 browser details YourSeq 219 1180 1839 3000 95.1% chr5 + 114186580 114187331 752 browser details YourSeq 206 1132 1499 3000 90.4% chr5 + 24396242 24396574 333 browser details YourSeq 205 1180 1499 3000 95.2% chr2 + 181558942 181559566 625 browser details YourSeq 204 1189 1499 3000 91.3% chr9 - 110030248 110030507 260 browser details YourSeq 204 1027 1504 3000 94.1% chr13 - 43664039 43664512 474 browser details YourSeq 204 1320 1874 3000 88.8% chr7 + 30109550 30110041 492 browser details YourSeq 203 1180 1499 3000 91.3% chr16 + 17184087 17184362 276 browser details YourSeq 202 958 1867 3000 85.0% chr1 - 182074878 182075199 322 browser details YourSeq 201 1029 1499 3000 97.3% chr7 - 44963326 44963827 502 browser details YourSeq 201 1320 1662 3000 97.7% chr19 - 59106527 59107038 512 browser details YourSeq 201 1021 1499 3000 95.9% chr6 + 33855036 33855564 529 browser details YourSeq 198 1320 1855 3000 91.5% chr6 - 49192089 49192563 475 browser details YourSeq 197 1320 1769 3000 88.7% chr13 - 119787899 119788173 275 Note: The 3000 bp section upstream of Exon 3 is BLAT searched against the genome. No significant similarity is found. BLAT Search Results (down) QUERY SCORE START END QSIZE IDENTITY CHROM STRAND START END SPAN ----------------------------------------------------------------------------------------------- browser details YourSeq 3000 1 3000 3000 100.0% chr16 + 93844578 93847577 3000 browser details YourSeq 111 1141 1401 3000 83.0% chr16 + 93837503 93837682 180 browser details YourSeq 103 1143 1545 3000 93.2% chr15 - 102872140 103166666 294527 browser details YourSeq 81 1142 1512 3000 93.5% chr15 + 12380343 12474388 94046 browser details YourSeq 77 1405 1550 3000 92.3% chr6 - 148523541 148943084 419544 browser details YourSeq 77 1401 1563 3000 93.4% chr13 - 43659698 43659911 214 browser details YourSeq 72 1401 1550 3000 91.8% chr11 - 77891385 77891673 289 browser details YourSeq 71 1476 1617 3000 77.3% chr4 + 151959151 151959258 108 browser details YourSeq 66 1480 1855 3000 77.7% chr8 - 85661386 85661699 314 browser details YourSeq 64 1302 1463 3000 89.2% chrX - 122001370 122001789 420 browser details YourSeq 61 1519 1867 3000 92.0% chr5 - 124553527 124553959 433 browser details YourSeq 60 1146 1542 3000 88.7% chr11 - 76068661 76069229 569 browser details YourSeq 60 1420 1550 3000 91.6% chr4 + 109007207 109007476 270 browser details YourSeq 57 1480 1568 3000 94.0% chr11 - 117719292 117719382 91 browser details YourSeq 57 1489 1617 3000 95.3% chr3 + 149634255 149634417 163 browser details YourSeq 56 1479 1563 3000 93.8% chr2 + 74493337 74493424 88 browser details YourSeq 55 1481 1568 3000 92.2% chr12 + 87346418 87346507 90 browser details YourSeq 55 1421 1497 3000 89.9% chr10 + 108755098 108755395 298 browser details YourSeq 54 2300 2495 3000 77.1% chr12 - 25337324 25337495 172 browser details YourSeq 53 1491 1761 3000 93.4% chr2 + 23031485 23032008 524 Note: The 3000 bp section downstream of Exon 3 is BLAT searched against the genome. No significant similarity is found. Page 4 of 8 https://www.alphaknockout.com Gene and protein information: Morc3 microrchidia 3 [ Mus musculus (house mouse) ] Gene ID: 338467, updated on 12-Aug-2019 Gene summary Official Symbol Morc3 provided by MGI Official Full Name microrchidia 3 provided by MGI Primary source MGI:MGI:2136841 See related Ensembl:ENSMUSG00000039456 Gene type protein coding RefSeq status VALIDATED Organism Mus musculus Lineage Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia; Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae; Murinae; Mus; Mus Also known as NXP2; Zcwcc3; AI452146; BF318192; D16Jhu32e; 1110051N18Rik Expression Ubiquitous expression in CNS E18 (RPKM 8.1), CNS E11.5 (RPKM 7.9) and 27 other tissues See more Orthologs human all Genomic context Location: 16; 16 C4 See Morc3 in Genome Data Viewer Exon count: 18 Annotation release Status Assembly Chr Location 108 current GRCm38.p6 (GCF_000001635.26) 16 NC_000082.6 (93832121..93876077) Build 37.2 previous assembly MGSCv37 (GCF_000001635.18) 16 NC_000082.5 (93832366..93876318) Chromosome 16 - NC_000082.6 Page 5 of 8 https://www.alphaknockout.com Transcript information: This gene has 10 transcripts Gene: Morc3 ENSMUSG00000039456 Description microrchidia 3 [Source:MGI Symbol;Acc:MGI:2136841] Gene Synonyms 1110051N18Rik, D16Jhu32e, Zcwcc3 Location Chromosome 16: 93,832,121-93,876,073 forward strand. GRCm38:CM001009.2 About this gene This gene has 10 transcripts (splice variants), 137 orthologues, 1 paralogue, is a member of 1 Ensembl protein family and is associated with 3 phenotypes. Transcripts Name Transcript ID bp Protein Translation ID Biotype CCDS UniProt Flags Morc3- ENSMUST00000202261.4 4179 942aa ENSMUSP00000144369.1 Protein coding CCDS79490 F7BJB9 TSL:1 206 GENCODE basic APPRIS P1 Morc3- ENSMUST00000044068.9 4178 942aa ENSMUSP00000040152.6 Protein coding - F7BJB9 TSL:5 201 GENCODE basic APPRIS P1 Morc3- ENSMUST00000201097.2 1386 397aa ENSMUSP00000144058.2 Protein coding - A0A0J9YU83 CDS 3' 202 incomplete TSL:5 Morc3- ENSMUST00000201754.3 1298 92aa ENSMUSP00000144357.1 Nonsense mediated - A0A0J9YUV3 TSL:1 205 decay Morc3- ENSMUST00000232639.1 726 58aa ENSMUSP00000156167.1 Nonsense mediated - A0A338P7B1 CDS 5' 210 decay incomplete Morc3- ENSMUST00000232425.1 2114 No - Retained intron - - - 209 protein Morc3- ENSMUST00000202663.1 882 No - Retained intron - - TSL:3 207 protein Morc3- ENSMUST00000201497.1 735 No - Retained intron - - TSL:2 203 protein Morc3- ENSMUST00000201706.1 634 No - Retained intron - - TSL:3 204 protein Morc3- ENSMUST00000231891.1 246 No - Retained intron - - - 208 protein Page 6 of 8 https://www.alphaknockout.com 63.95 kb Forward strand 93.83Mb 93.84Mb 93.85Mb 93.86Mb 93.87Mb 93.88Mb Genes (Comprehensive set... Morc3-201 >protein coding Chaf1b-204 >retained intron Morc3-206 >protein coding Chaf1b-201 >protein coding Morc3-203 >retained intron Morc3-208 >retained intron Morc3-210 >nonsense mediated decay Chaf1b-202 >protein coding Morc3-202 >protein coding Chaf1b-206 >protein coding Morc3-205 >nonsense mediated decay Chaf1b-203 >protein coding Morc3-209 >retained intron Morc3-207 >retained intronMorc3-204 >retained intron Contigs < AC168220.1 Genes < Gm30881-201lncRNA (Comprehensive set... Regulatory Build 93.83Mb 93.84Mb 93.85Mb 93.86Mb 93.87Mb 93.88Mb Reverse strand 63.95 kb Regulation Legend CTCF Enhancer Open Chromatin Promoter Promoter Flank Gene Legend
Load more

Recommended publications
  • Molecular Mechanism of the MORC4 Atpase Activation
    ARTICLE https://doi.org/10.1038/s41467-020-19278-8 OPEN Molecular mechanism of the MORC4 ATPase activation Adam H. Tencer1, Khan L. Cox2, Gregory M. Wright1, Yi Zhang 1, Christopher J. Petell3, Brianna J. Klein1, ✉ Brian D. Strahl 3, Joshua C. Black1, Michael G. Poirier2 & Tatiana G. Kutateladze 1 Human Microrchidia 4 (MORC4) is associated with acute and chronic pancreatitis, inflam- matory disorders and cancer but it remains largely uncharacterized. Here, we describe the 1234567890():,; structure–function relationship of MORC4 and define the molecular mechanism for MORC4 activation. Enzymatic and binding assays reveal that MORC4 has ATPase activity, which is dependent on DNA-binding functions of both the ATPase domain and CW domain of MORC4. The crystal structure of the ATPaseCW cassette of MORC4 and mutagenesis studies show that the DNA-binding site and the histone/ATPase binding site of CW are located on the opposite sides of the domain. The ATPase and CW domains cooperate in binding of MORC4 to the nucleosome core particle (NCP), enhancing the DNA wrapping around the histone core and impeding binding of DNA-associated proteins, such as tran- scription factors, to the NCP. In cells, MORC4 mediates formation of nuclear bodies in the nucleus and has a role in the progression of S-phase of the cell cycle, and both these functions require CW and catalytic activity of MORC4. Our findings highlight the mechanism for MORC4 activation, which is distinctly different from the mechanisms of action observed in other MORC family members. 1 Department of Pharmacology, University of Colorado School of Medicine, Aurora, CO 80045, USA.
    [Show full text]
  • ARTICLE Classification of Human Chromosome 21 Gene-Expression Variations in Down Syndrome: Impact on Disease Phenotypes
    ARTICLE Classification of Human Chromosome 21 Gene-Expression Variations in Down Syndrome: Impact on Disease Phenotypes E. Aı¨t Yahya-Graison, J. Aubert, L. Dauphinot, I. Rivals, M. Prieur, G. Golfier, J. Rossier, L. Personnaz, N. Cre´au, H. Ble´haut, S. Robin, J. M. Delabar, and M.-C. Potier Down syndrome caused by chromosome 21 trisomy is the most common genetic cause of mental retardation in humans. Disruption of the phenotype is thought to be the result of gene-dosage imbalance. Variations in chromosome 21 gene expression in Down syndrome were analyzed in lymphoblastoid cells derived from patients and control individuals. Of the 359 genes and predictions displayed on a specifically designed high-content chromosome 21 microarray, one-third were expressed in lymphoblastoid cells. We performed a mixed-model analysis of variance to find genes that are differ- entially expressed in Down syndrome independent of sex and interindividual variations. In addition, we identified genes with variations between Down syndrome and control samples that were significantly different from the gene-dosage effect (1.5). Microarray data were validated by quantitative polymerase chain reaction. We found that 29% of the expressed chromosome 21 transcripts are overexpressed in Down syndrome and correspond to either genes or open reading frames. Among these, 22% are increased proportional to the gene-dosage effect, and 7% are amplified. The other 71% of expressed sequences are either compensated (56%, with a large proportion of predicted genes and antisense transcripts) or highly variable among individuals (15%). Thus, most of the chromosome 21 transcripts are compensated for the gene-dosage effect.
    [Show full text]
  • Whole-Genome Linkage Scan Combined with Exome Sequencing Identifies Novel Candidate Genes for Carotid Intima-Media Thickness
    fgene-09-00420 October 5, 2018 Time: 14:5 # 1 ORIGINAL RESEARCH published: 09 October 2018 doi: 10.3389/fgene.2018.00420 Whole-Genome Linkage Scan Combined With Exome Sequencing Identifies Novel Candidate Genes for Carotid Intima-Media Thickness Dina Vojinovic1, Maryam Kavousi1, Mohsen Ghanbari1,2, Rutger W. W. Brouwer3, Jeroen G. J. van Rooij4, Mirjam C. G. N. van den Hout3, Robert Kraaij4, Wilfred F. J. van Ijcken3, Andre G. Uitterlinden1,4, Cornelia M. van Duijn1,5 and Najaf Amin1* 1 Department of Epidemiology, Erasmus MC University Medical Center, Rotterdam, Netherlands, 2 Department of Genetics, School of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran, 3 Department of Cell Biology, Center for Biomics, Erasmus MC University Medical Center, Rotterdam, Netherlands, 4 Department of Internal Medicine, Erasmus MC University Medical Center, Rotterdam, Netherlands, 5 Nuffield Department of Population Health, University of Oxford, Oxford, United Kingdom Carotid intima-media thickness (cIMT) is an established heritable marker for subclinical atherosclerosis. In this study, we aim to identify rare variants with large effects driving Edited by: differences in cIMT by performing genome-wide linkage analysis of individuals in the Robert Klein, extremes of cIMT trait distribution (>90th percentile) in a large family-based study from Icahn School of Medicine at Mount a genetically isolated population in the Netherlands. Linked regions were subsequently Sinai, United States explored by fine-mapping using exome sequencing. We observed significant evidence Reviewed by: Elizabeth Hauser, of linkage on chromosomes 2p16.3 [rs1017418, heterogeneity LOD (HLOD) = 3.35], Duke University, United States 19q13.43 (rs3499, HLOD = 9.09), 20p13 (rs1434789, HLOD = 4.10), and 21q22.12 Mark Z.
    [Show full text]
  • Mouse MORC3 Is a GHKL Atpase That Localizes to H3k4me3 Marked Chromatin
    Mouse MORC3 is a GHKL ATPase that localizes to H3K4me3 marked chromatin Sisi Lia,1,2, Linda Yenb,1, William A. Pastorb, Jonathan B. Johnstonc, Jiamu Dud, Colin J. Shewb, Wanlu Liue, Jamie Hob, Bryan Stenderb, Amander T. Clarkb,e,f,g, Alma L. Burlingamec, Lucia Daxingerh,3, Dinshaw J. Patela,3, and Steven E. Jacobsenb,f,i,3 aStructural Biology Program, Memorial Sloan Kettering Cancer Center, New York, NY 10065; bDepartment of Molecular, Cell, and Developmental Biology, University of California, Los Angeles, CA 90095; cDepartment of Pharmaceutical Chemistry, University of California, San Francisco, CA 94158; dShanghai Center for Plant Stress Biology, Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences, Shanghai 201602, China; eMolecular Biology Institute, University of California, Los Angeles, CA 90095; fEli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research, University of California, Los Angeles, CA 90095; gJonsson Comprehensive Cancer Center, University of California, Los Angeles, CA 90095; hDepartment of Human and Clinical Genetics, Leiden University Medical Center, 2300 RC Leiden, The Netherlands; and iHoward Hughes Medical Institute, University of California, Los Angeles, CA 90095 Contributed by Steven E. Jacobsen, June 16, 2016 (sent for review May 16, 2016; reviewed by Shiv I. S. Grewal and Fei Lan) Microrchidia (MORC) proteins are GHKL (gyrase, heat-shock protein dimethylation and trimethylation marks (H3K4me2 and H3K4me3) 90, histidine kinase, MutL) ATPases that function in gene regulation in (11–13). Consistent with this hypothesis, human and murine MORC3 multiple organisms. Animal MORCs also contain CW-type zinc finger have been identified in mass spectrometry screens as H3K4me3 domains, which are known to bind to modified histones.
    [Show full text]
  • Increased Dosage of the Chromosome 21 Ortholog Dyrk1a Promotes Megakaryoblastic Leukemia in a Murine Model of Down Syndrome
    Increased dosage of the chromosome 21 ortholog Dyrk1a promotes megakaryoblastic leukemia in a murine model of Down syndrome Sébastien Malinge, … , Sandeep Gurbuxani, John D. Crispino J Clin Invest. 2012;122(3):948-962. https://doi.org/10.1172/JCI60455. Research Article Individuals with Down syndrome (DS; also known as trisomy 21) have a markedly increased risk of leukemia in childhood but a decreased risk of solid tumors in adulthood. Acquired mutations in the transcription factor–encoding GATA1 gene are observed in nearly all individuals with DS who are born with transient myeloproliferative disorder (TMD), a clonal preleukemia, and/or who develop acute megakaryoblastic leukemia (AMKL). Individuals who do not have DS but bear germline GATA1 mutations analogous to those detected in individuals with TMD and DS-AMKL are not predisposed to leukemia. To better understand the functional contribution of trisomy 21 to leukemogenesis, we used mouse and human cell models of DS to reproduce the multistep pathogenesis of DS-AMKL and to identify chromosome 21 genes that promote megakaryoblastic leukemia in children with DS. Our results revealed that trisomy for only 33 orthologs of human chromosome 21 (Hsa21) genes was sufficient to cooperate with GATA1 mutations to initiate megakaryoblastic leukemia in vivo. Furthermore, through a functional screening of the trisomic genes, we demonstrated that DYRK1A, which encodes dual-specificity tyrosine-(Y)-phosphorylation–regulated kinase 1A, was a potent megakaryoblastic tumor–promoting gene that contributed
    [Show full text]
  • Morphology, Behavior, and the Sonic Hedgehog Pathway in Mouse Models of Down Syndrome
    MORPHOLOGY, BEHAVIOR, AND THE SONIC HEDGEHOG PATHWAY IN MOUSE MODELS OF DOWN SYNDROME by Tara Dutka A dissertation submitted to Johns Hopkins University in conformity with the requirements for the degree of Doctor of Philosophy Baltimore, Maryland July, 2014 © 2014 Tara Dutka All Rights Reserved Abstract Down Syndrome (DS) is caused by a triplication of human chromosome 21 (Hsa21). Ts65Dn, a mouse model of DS, contains a freely segregating extra chromosome consisting of the distal portion of mouse chromosome 16 (Mmu16), a region orthologous to part of Hsa21, and a non-Hsa21 orthologous region of mouse chromosome 17. All individuals with DS display some level of craniofacial dysmorphology, brain structural and functional changes, and cognitive impairment. Ts65Dn recapitulates these features of DS and aspects of each of these traits have been linked in Ts65Dn to a reduced response to Sonic Hedgehog (SHH) in trisomic cells. Dp(16)1Yey is a new mouse model of DS which has a direct duplication of the entire Hsa21 orthologous region of Mmu16. Dp(16)1Yey’s creators found similar behavioral deficits to those seen in Ts65Dn. We performed a quantitative investigation of the skull and brain of Dp(16)1Yey as compared to Ts65Dn and found that DS-like changes to brain and craniofacial morphology were similar in both models. Our results validate examination of the genetic basis for these phenotypes in Dp(16)1Yey mice and the genetic links for these phenotypes previously found in Ts65Dn , i.e., reduced response to SHH. Further, we hypothesized that if all trisomic cells show a reduced response to SHH, then up-regulation of the SHH pathway might ameliorate multiple phenotypes.
    [Show full text]
  • Genome-Wide Gene Expression Analysis in the Placenta from Fetus with Trisomy 21
    Lim et al. BMC Genomics (2017) 18:720 DOI 10.1186/s12864-017-3993-y RESEARCHARTICLE Open Access Genome-wide gene expression analysis in the placenta from fetus with trisomy 21 Ji Hyae Lim1†, You Jung Han2,3†, Hyun Jin Kim1, Dong Wook Kwak2, So Yeon Park1, Sun-Hee Chun3* and Hyun Mee Ryu1,2* Abstract Background: We performed whole human genome expression analysis in placenta tissue (normal and T21) samples in order to investigate gene expression into the pathogenesis of trisomy 21 (T21) placenta. We profiled the whole human genome expression of placental samples from normal and T21 fetuses using the GeneChip Human Genome U133 plus 2.0 array. Based on these data, we predicted the functions of differentially expressed genes using bioinformatics tools. Results: A total of 110 genes had different expression patterns in the T21 placentas than they did in the normal placentas. Among them, 77 genes were up-regulated in the T21 placenta and 33 genes were down-regulated compared to their respective levels in normal placentas. Over half of the up-regulated genes (59.7%, n =46)were located on HSA21. Up-regulated genes in the T21 placentas were significantly associated with T21 and its complications including mental retardation and neurobehavioral manifestations, whereas down-regulated genes were significantly associated with diseases, such as cystitis, metaplasia, pathologic neovascularization, airway obstruction, and diabetes mellitus. The interactive signaling network showed that 53 genes (40 up-regulated genes and 13 down- regulated genes) were an essential component of the dynamic complex of signaling (P < 1.39e-08). Conclusions: Our findings provide a broad overview of whole human genome expression in the placentas of fetuses with T21 and a possibility that these genes regulate biological pathways that have been involved in T21 and T21 complications.
    [Show full text]
  • Content Based Search in Gene Expression Databases and a Meta-Analysis of Host Responses to Infection
    Content Based Search in Gene Expression Databases and a Meta-analysis of Host Responses to Infection A Thesis Submitted to the Faculty of Drexel University by Francis X. Bell in partial fulfillment of the requirements for the degree of Doctor of Philosophy November 2015 c Copyright 2015 Francis X. Bell. All Rights Reserved. ii Acknowledgments I would like to acknowledge and thank my advisor, Dr. Ahmet Sacan. Without his advice, support, and patience I would not have been able to accomplish all that I have. I would also like to thank my committee members and the Biomed Faculty that have guided me. I would like to give a special thanks for the members of the bioinformatics lab, in particular the members of the Sacan lab: Rehman Qureshi, Daisy Heng Yang, April Chunyu Zhao, and Yiqian Zhou. Thank you for creating a pleasant and friendly environment in the lab. I give the members of my family my sincerest gratitude for all that they have done for me. I cannot begin to repay my parents for their sacrifices. I am eternally grateful for everything they have done. The support of my sisters and their encouragement gave me the strength to persevere to the end. iii Table of Contents LIST OF TABLES.......................................................................... vii LIST OF FIGURES ........................................................................ xiv ABSTRACT ................................................................................ xvii 1. A BRIEF INTRODUCTION TO GENE EXPRESSION............................. 1 1.1 Central Dogma of Molecular Biology........................................... 1 1.1.1 Basic Transfers .......................................................... 1 1.1.2 Uncommon Transfers ................................................... 3 1.2 Gene Expression ................................................................. 4 1.2.1 Estimating Gene Expression ............................................ 4 1.2.2 DNA Microarrays ......................................................
    [Show full text]
  • Skeletal Muscle Function, Morphology, and Biochemistry in Ts65dn Mice: a Model of Down Syndrome
    Syracuse University SURFACE Exercise Science - Dissertations School of Education 12-2011 Skeletal Muscle Function, Morphology, and Biochemistry in Ts65Dn Mice: A Model of Down Syndrome Patrick Michael Cowley Syracuse University Follow this and additional works at: https://surface.syr.edu/ppe_etd Part of the Kinesiology Commons Recommended Citation Cowley, Patrick Michael, "Skeletal Muscle Function, Morphology, and Biochemistry in Ts65Dn Mice: A Model of Down Syndrome" (2011). Exercise Science - Dissertations. 5. https://surface.syr.edu/ppe_etd/5 This Dissertation is brought to you for free and open access by the School of Education at SURFACE. It has been accepted for inclusion in Exercise Science - Dissertations by an authorized administrator of SURFACE. For more information, please contact [email protected]. ABSTRACT A common clinical observation of persons with Down syndrome at all developmental stages is hypotonia and generalized muscle weakness. The cause of muscle weakness in Down syndrome is not known and there is an immediate need to establish an acceptable animal model to explore the muscle dysfunction that is widely reported in the human population. Using a combination of functional, histological, and biochemical analyses this dissertation provides the initial characterization of skeletal muscle from the Ts65Dn mouse, a model of Down syndrome. The experiments revealed that Ts65Dn muscle over-expresses SOD1 protein but this did not lead to oxidative stress. Ts65Dn soleus muscles displayed normal force generation in the unfatigued state, but exhibited muscle weakness following fatiguing contractions. We show that a reduction in cytochrome c oxidase expression may contribute to the impaired muscle performance in Ts65Dn soleus. These findings support the use of the Ts65Dn mouse model of Down syndrome to delineate mechanisms of muscle dysfunction in the human condition.
    [Show full text]
  • Integrated Functional Genomic Analysis Enables Annotation of Kidney Genome-Wide Association Study Loci
    BASIC RESEARCH www.jasn.org Integrated Functional Genomic Analysis Enables Annotation of Kidney Genome-Wide Association Study Loci Karsten B. Sieber,1 Anna Batorsky,2 Kyle Siebenthall,2 Kelly L. Hudkins,3 Jeff D. Vierstra,2 Shawn Sullivan,4 Aakash Sur,4,5 Michelle McNulty,6 Richard Sandstrom,2 Alex Reynolds,2 Daniel Bates,2 Morgan Diegel,2 Douglass Dunn,2 Jemma Nelson,2 Michael Buckley,2 Rajinder Kaul,2 Matthew G. Sampson,6 Jonathan Himmelfarb,7,8 Charles E. Alpers,3,8 Dawn Waterworth,1 and Shreeram Akilesh3,8 Due to the number of contributing authors, the affiliations are listed at the end of this article. ABSTRACT Background Linking genetic risk loci identified by genome-wide association studies (GWAS) to their causal genes remains a major challenge. Disease-associated genetic variants are concentrated in regions con- taining regulatory DNA elements, such as promoters and enhancers. Although researchers have previ- ously published DNA maps of these regulatory regions for kidney tubule cells and glomerular endothelial cells, maps for podocytes and mesangial cells have not been available. Methods We generated regulatory DNA maps (DNase-seq) and paired gene expression profiles (RNA-seq) from primary outgrowth cultures of human glomeruli that were composed mainly of podo- cytes and mesangial cells. We generated similar datasets from renal cortex cultures, to compare with those of the glomerular cultures. Because regulatory DNA elements can act on target genes across large genomic distances, we also generated a chromatin conformation map from freshly isolated human glomeruli. Results We identified thousands of unique regulatory DNA elements, many located close to transcription factor genes, which the glomerular and cortex samples expressed at different levels.
    [Show full text]
  • Nucleosome Plasticity Is a Critical Element of Chromatin Liquidâ
    ARTICLE https://doi.org/10.1038/s41467-021-23090-3 OPEN Nucleosome plasticity is a critical element of chromatin liquid–liquid phase separation and multivalent nucleosome interactions Stephen E. Farr1, Esmae J. Woods 1, Jerelle A. Joseph 1,2,3, Adiran Garaizar 1 & ✉ Rosana Collepardo-Guevara 1,2,3 – 1234567890():,; Liquid liquid phase separation (LLPS) is an important mechanism that helps explain the membraneless compartmentalization of the nucleus. Because chromatin compaction and LLPS are collective phenomena, linking their modulation to the physicochemical features of nucleosomes is challenging. Here, we develop an advanced multiscale chromatin model— integrating atomistic representations, a chemically-specific coarse-grained model, and a minimal model—to resolve individual nucleosomes within sub-Mb chromatin domains and phase-separated systems. To overcome the difficulty of sampling chromatin at high resolu- tion, we devise a transferable enhanced-sampling Debye-length replica-exchange molecular dynamics approach. We find that nucleosome thermal fluctuations become significant at physiological salt concentrations and destabilize the 30-nm fiber. Our simulations show that nucleosome breathing favors stochastic folding of chromatin and promotes LLPS by simul- taneously boosting the transient nature and heterogeneity of nucleosome–nucleosome contacts, and the effective nucleosome valency. Our work puts forward the intrinsic plasticity of nucleosomes as a key element in the liquid-like behavior of nucleosomes within chromatin, and the regulation
    [Show full text]
  • Published Version
    PUBLISHED VERSION King-Hwa Ling, Chelsee A Hewitt, Kai-Leng Tan, Pike-See Cheah, Sharmili Vidyadaran, Mei-I Lai, Han- Chung Lee, Ken Simpson, Lavinia Hyde, Melanie A Pritchard, Gordon K Smyth, Tim Thomas, and Hamish S Scott Functional transcriptome analysis of the postnatal brain of the Ts1Cje mouse model for Down syndrome reveals global disruption of interferon-related molecular networks BMC Genomics, 2014; 15(1):624-1-624-19 © 2014 Ling et al.; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. Originally published at: http://doi.org/10.1186/1471-2164-15-624 PERMISSIONS http://creativecommons.org/licenses/by/4.0/ http://hdl.handle.net/2440/97389 Ling et al. BMC Genomics 2014, 15:624 http://www.biomedcentral.com/1471-2164/15/624 RESEARCH ARTICLE Open Access Functional transcriptome analysis of the postnatal brain of the Ts1Cje mouse model for Down syndrome reveals global disruption of interferon-related molecular networks King-Hwa Ling1,2,3*†, Chelsee A Hewitt2,4†, Kai-Leng Tan1,5†, Pike-See Cheah1,5, Sharmili Vidyadaran1,6, Mei-I Lai1,6, Han-Chung Lee1, Ken Simpson2, Lavinia Hyde2, Melanie A Pritchard7, Gordon K Smyth2, Tim Thomas2 and Hamish S Scott2,8,9* Abstract Background: The Ts1Cje mouse model of Down syndrome (DS) has partial triplication of mouse chromosome 16 (MMU16), which is partially homologous to human chromosome 21.
    [Show full text]